Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug

Hits: 2

A third member of a key FDA panel has resigned over the agency’s controversial decision to approve Biogen’s new Alzheimer’s drug, Aduhelm, CNBC has learned. Read More Go To Source

Be the first to comment

Leave a Reply

Your email address will not be published.


*


two × one =